期刊
EUROPEAN JOURNAL OF HUMAN GENETICS
卷 26, 期 1, 页码 12-33出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/s41431-017-0016-z
关键词
Assisted reproductive technology; Epigenetics; Expanded carrier screening; Gamete donor anonymity; Germline genome editing; Female infertility; Male infertility; Mitochondrial replacement therapy; Non-invasive prenatal testing; Preimplantation genetic testing
资金
- European Society of Human Reproduction and Embryology
- European Society of Human Genetics
- Czech Ministry of Health and Czech Ministry of Youth, Education and Sports [IP00064203/6003, CZ.2.16/3.1.00/24022, CZ.02.1.01/0.0/0.0/16_013/0001634, LM2015091]
Two leading European professional societies, the European Society of Human Genetics and the European Society for Human Reproduction and Embryology, have worked together since 2004 to evaluate the impact of fast research advances at the interface of assisted reproduction and genetics, including their application into clinical practice. In September 2016, the expert panel met for the third time. The topics discussed highlighted important issues covering the impacts of expanded carrier screening, direct-to-consumer genetic testing, voiding of the presumed anonymity of gamete donors by advanced genetic testing, advances in the research of genetic causes underlying male and female infertility, utilisation of massively parallel sequencing in preimplantation genetic testing and non-invasive prenatal screening, mitochondrial replacement in human oocytes, and additionally, issues related to cross-generational epigenetic inheritance following IVF and germline genome editing. The resulting paper represents a consensus of both professional societies involved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据